List your company

ITO™ Platform

Drug discovery and biotech · by 1910

Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates faster and more reliably than traditional methods.

Visit website

Where it ranks

Current edition · updated Oct 20, 2026

What it does

Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates faster and more reliably than traditional methods.

  • Small and large molecule drug discovery
  • Precision target identification
  • Macrocyclic peptide drug discovery
  • CNS penetration prediction for small molecules
  • Federated learning for multi-company AI model training
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
Biotech companies, Pharmaceutical companies
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

1910 doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

1910 hasn't published certifications or security practices for ITO™ Platform that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use ITO™ Platform at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

See the full ranking

  • Chai-2 Platform

    by Chai Discovery

    AI platform for de novo protein design that works reliably.

    #1 in Design molecular candidates

  • DiffuseSandbox

    by Diffuse Bio

    Sandbox for designing novel protein binders, enabling binder design in minutes on a laptop compared to spending weeks in a lab.

    #2 in Design molecular candidates

  • PharmaSphere

    by Receptor.AI

    AI drug design platform with dedicated sub-platforms for Small Molecules, Peptides, and Proximity Inducers, combining 40+ experimentally validated AI methodologies for molecular...

    #4 in Design molecular candidates

  • DeepChain Labs

    by DeepChain

    Experimental interface for multi-objective optimisation and interactive conditioning for flexible antibody design.

    #5 in Design molecular candidates

  • DrugFlow Platform

    by DrugFlow

    AI-driven one-stop new drug discovery platform with proprietary core algorithms covering the entire drug discovery process, including target discovery, lead compound discovery,...

    #6 in Design molecular candidates

  • SAR & De Novo

    by META D3

    AI powered Drug Discovery and Development platform for drug discovery steps from target identification to clinical trial success, associated with Partex.

    #7 in Design molecular candidates

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim ITO™ Platform